Regulation of senescence escape by the cdk4–EZH2–AP2M1 pathway in response to chemotherapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of senescence escape by the cdk4–EZH2–AP2M1 pathway in response to chemotherapy
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 2, Pages -
Publisher
Springer Nature
Online
2018-02-08
DOI
10.1038/s41419-017-0209-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence
- (2015) Sharon Brookes et al. CELL CYCLE
- Prediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples
- (2015) Mario Campone et al. MOLECULAR & CELLULAR PROTEOMICS
- Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosis
- (2015) Alexandra Vétillard et al. Oncotarget
- Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1
- (2015) Barbara Jonchère et al. Oncotarget
- Level of macroautophagy drives senescent keratinocytes into cell death or neoplastic evasion
- (2014) E Deruy et al. Cell Death & Disease
- Regulation of p53 and Rb Links the Alternative NF-κB Pathway to EZH2 Expression and Cell Senescence
- (2014) Alessio Iannetti et al. PLoS Genetics
- Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
- (2013) Eunhee Kim et al. CANCER CELL
- MEK drives cyclin D1 hyperelevation during geroconversion
- (2013) O V Leontieva et al. CELL DEATH AND DIFFERENTIATION
- Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis
- (2012) L. C. W. Vredeveld et al. GENES & DEVELOPMENT
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- New-found fundamentals of bacterial persistence
- (2012) Cyrielle I. Kint et al. TRENDS IN MICROBIOLOGY
- Escape from p21-mediated Oncogene-induced Senescence Leads to Cell Dedifferentiation and Dependence on Anti-apoptotic Bcl-xL and MCL1 Proteins
- (2011) Sophie de Carné Trécesson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Four faces of cellular senescence
- (2011) Francis Rodier et al. JOURNAL OF CELL BIOLOGY
- A Quantitative Proteomic Approach of the Different Stages of Colorectal Cancer Establishes OLFM4 as a New Nonmetastatic Tumor Marker
- (2011) Damien Besson et al. MOLECULAR & CELLULAR PROTEOMICS
- Molecular mechanism and physiological functions of clathrin-mediated endocytosis
- (2011) Harvey T. McMahon et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Senescence-Associated Oxidative DNA Damage Promotes the Generation of Neoplastic Cells
- (2009) K. Gosselin et al. CANCER RESEARCH
- Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS
- (2009) M. Barradas et al. GENES & DEVELOPMENT
- The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence
- (2009) K. Agger et al. GENES & DEVELOPMENT
- Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
- (2009) Francis Rodier et al. NATURE CELL BIOLOGY
- The EGFR-STAT3 Oncogenic Pathway Up-regulates the Eme1 Endonuclease to Reduce DNA Damage after Topoisomerase I Inhibition
- (2008) A. Vigneron et al. CANCER RESEARCH
- Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
- (2008) Thomas Kuilman et al. CELL
- Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
- (2008) Jean-Philippe Coppé et al. PLOS BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More